O
6.09
0.06 (1.00%)
| Previous Close | 6.03 |
| Open | 6.15 |
| Volume | 5,919,955 |
| Avg. Volume (3M) | 4,980,540 |
| Market Cap | 1,585,322,368 |
| Price / Earnings (TTM) | 8.46 |
| Price / Sales | 0.270 |
| Price / Book | 2.20 |
| 52 Weeks Range | |
| Earnings Date | 30 Apr 2026 |
| TTM Dividend Yield | 11.41% |
| Profit Margin | 11.92% |
| Operating Margin (TTM) | 22.08% |
| Diluted EPS (TTM) | 2.88 |
| Quarterly Revenue Growth (YOY) | -6.70% |
| Quarterly Earnings Growth (YOY) | -56.70% |
| Total Debt/Equity (MRQ) | 1,652.40% |
| Current Ratio (MRQ) | 1.67 |
| Operating Cash Flow (TTM) | 938.00 M |
| Levered Free Cash Flow (TTM) | 462.38 M |
| Return on Assets (TTM) | 7.03% |
| Return on Equity (TTM) | 254.24% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Drug Manufacturers - General (US) | Bullish | Mixed |
| Drug Manufacturers - General (Global) | Bullish | Mixed | |
| Stock | Organon & Co. | Bearish | Bearish |
AIStockmoo Score
-0.8
| Analyst Consensus | -0.5 |
| Insider Activity | -4.0 |
| Price Volatility | 0.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -2.5 |
| Average | -0.80 |
|
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women’s health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio. |
|
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Investment Style | Small Value |
| % Held by Insiders | 0.24% |
| % Held by Institutions | 80.34% |
| 52 Weeks Range | ||
| Median | 8.00 (31.36%) | |
| Total | 1 Sell | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Barclays | 24 Feb 2026 | 8.00 (31.36%) | Sell | 8.14 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| ARJONA FERREIRA JUAN CAMILO | - | 5.92 | -8,001 | -47,449 |
| DRINANE JULIANA PAPA | - | 5.92 | -8,369 | -49,720 |
| FALCIONE AARON | - | 5.92 | -9,025 | -53,627 |
| HOLZBAUR LYNETTE | - | 5.92 | -4,642 | -27,578 |
| KARP DANIEL | - | 5.92 | -10,105 | -59,862 |
| MORRISSEY JOSEPH T. JR. | - | 5.92 | -9,784 | -58,189 |
| NISITA VITTORIO | - | 5.92 | -6,427 | -38,202 |
| STAHLER RACHEL A | - | 5.92 | -9,272 | -55,118 |
| WALSH MATTHEW M | - | 5.92 | -16,669 | -99,073 |
| WEAVER KIRKE | - | 5.92 | -7,485 | -44,504 |
| Aggregate Net Quantity | -89,779 | |||
| Aggregate Net Value ($) | -533,322 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 5.92 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| MORRISSEY JOSEPH T. JR. | Officer | 31 Mar 2026 | Disposed (-) | 7,005 | 5.99 | 41,960 |
| MORRISSEY JOSEPH T. JR. | Officer | 31 Mar 2026 | Option execute | 24,584 | - | - |
| HOLZBAUR LYNETTE | Officer | 31 Mar 2026 | Disposed (-) | 3,126 | 5.99 | 18,725 |
| HOLZBAUR LYNETTE | Officer | 31 Mar 2026 | Option execute | 10,967 | - | - |
| NISITA VITTORIO | Officer | 31 Mar 2026 | Disposed (-) | 4,453 | 5.99 | 26,673 |
| NISITA VITTORIO | Officer | 31 Mar 2026 | Option execute | 13,000 | - | - |
| WEAVER KIRKE | Officer | 31 Mar 2026 | Disposed (-) | 5,275 | 5.99 | 31,597 |
| WEAVER KIRKE | Officer | 31 Mar 2026 | Option execute | 18,513 | - | - |
| FALCIONE AARON | Officer | 31 Mar 2026 | Disposed (-) | 6,140 | 5.99 | 36,779 |
| FALCIONE AARON | Officer | 31 Mar 2026 | Option execute | 17,925 | - | - |
| WALSH MATTHEW M | Officer | 31 Mar 2026 | Disposed (-) | 11,507 | 5.99 | 68,927 |
| WALSH MATTHEW M | Officer | 31 Mar 2026 | Option execute | 33,593 | - | - |
| STAHLER RACHEL A | Officer | 31 Mar 2026 | Disposed (-) | 6,463 | 5.99 | 38,713 |
| STAHLER RACHEL A | Officer | 31 Mar 2026 | Option execute | 18,867 | - | - |
| KARP DANIEL | Officer | 31 Mar 2026 | Disposed (-) | 5,659 | 5.99 | 33,897 |
| KARP DANIEL | Officer | 31 Mar 2026 | Option execute | 18,053 | - | - |
| ARJONA FERREIRA JUAN CAMILO | Officer | 31 Mar 2026 | Disposed (-) | 4,820 | 5.99 | 28,872 |
| ARJONA FERREIRA JUAN CAMILO | Officer | 31 Mar 2026 | Option execute | 13,431 | - | - |
| DRINANE JULIANA PAPA | Officer | 31 Mar 2026 | Disposed (-) | 5,636 | 5.99 | 33,760 |
| DRINANE JULIANA PAPA | Officer | 31 Mar 2026 | Option execute | 16,451 | - | - |
| MORRISSEY JOSEPH T. JR. | Officer | 29 Mar 2026 | Disposed (-) | 2,779 | 5.84 | 16,229 |
| MORRISSEY JOSEPH T. JR. | Officer | 29 Mar 2026 | Option execute | 9,752 | - | - |
| WALSH MATTHEW M | Officer | 29 Mar 2026 | Disposed (-) | 5,162 | 5.84 | 30,146 |
| WALSH MATTHEW M | Officer | 29 Mar 2026 | Option execute | 15,071 | - | - |
| FALCIONE AARON | Officer | 29 Mar 2026 | Disposed (-) | 2,885 | 5.84 | 16,848 |
| FALCIONE AARON | Officer | 29 Mar 2026 | Option execute | 8,422 | - | - |
| ARJONA FERREIRA JUAN CAMILO | Officer | 29 Mar 2026 | Disposed (-) | 3,181 | 5.84 | 18,577 |
| ARJONA FERREIRA JUAN CAMILO | Officer | 29 Mar 2026 | Option execute | 8,865 | - | - |
| DRINANE JULIANA PAPA | Officer | 29 Mar 2026 | Disposed (-) | 2,733 | 5.84 | 15,961 |
| DRINANE JULIANA PAPA | Officer | 29 Mar 2026 | Option execute | 7,979 | - | - |
| NISITA VITTORIO | Officer | 29 Mar 2026 | Disposed (-) | 1,974 | 5.84 | 11,528 |
| NISITA VITTORIO | Officer | 29 Mar 2026 | Option execute | 5,762 | - | - |
| WEAVER KIRKE | Officer | 29 Mar 2026 | Disposed (-) | 2,210 | 5.84 | 12,906 |
| WEAVER KIRKE | Officer | 29 Mar 2026 | Option execute | 7,757 | - | - |
| KARP DANIEL | Officer | 29 Mar 2026 | Disposed (-) | 4,446 | 5.84 | 25,965 |
| KARP DANIEL | Officer | 29 Mar 2026 | Option execute | 14,184 | - | - |
| HOLZBAUR LYNETTE | Officer | 29 Mar 2026 | Disposed (-) | 1,516 | 5.84 | 8,853 |
| HOLZBAUR LYNETTE | Officer | 29 Mar 2026 | Option execute | 5,319 | - | - |
| STAHLER RACHEL A | Officer | 29 Mar 2026 | Disposed (-) | 2,809 | 5.84 | 16,405 |
| STAHLER RACHEL A | Officer | 29 Mar 2026 | Option execute | 8,200 | - | - |
| Show more | ||||||
| Date | Type | Details |
|---|---|---|
| 29 Jan 2026 | Announcement | Organon To Report Fourth Quarter and Full Year 2025 Results and Host Conference Call on February 12, 2026 |
| 28 Jan 2026 | Announcement | Organon Completes Divestiture of JADA® System to Laborie |
| 16 Jan 2026 | Announcement | Organon Announces US Food and Drug Administration Approval of Supplemental New Drug Application Extending Duration of Use of NEXPLANON® (etonogestrel implant) 68 mg Radiopaque |
| 08 Jan 2026 | Announcement | Organon Enters into a Commercialization Agreement for Daiichi Sankyo’s Nilemdo® in France, Denmark, Iceland, Sweden, Finland and Norway |
| TTM Dividend Yield | 11.41% |
| 5Y Average Dividend Yield | 5.21% |
| Payout Ratio | 38.89% |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 24 Feb 2025 | 13 Feb 2025 | 13 Mar 2025 | 0.28 Cash |
| 12 Nov 2024 | 31 Oct 2024 | 12 Dec 2024 | 0.28 Cash |
| 16 Aug 2024 | 06 Aug 2024 | 12 Sep 2024 | 0.28 Cash |
| 10 May 2024 | 02 May 2024 | 13 Jun 2024 | 0.28 Cash |
| 23 Feb 2024 | 15 Feb 2024 | 14 Mar 2024 | 0.28 Cash |
| 10 Nov 2023 | 02 Nov 2023 | 14 Dec 2023 | 0.28 Cash |
| 17 Aug 2023 | 08 Aug 2023 | 14 Sep 2023 | 0.28 Cash |
| 12 May 2023 | 04 May 2023 | 15 Jun 2023 | 0.28 Cash |
| 24 Feb 2023 | 16 Feb 2023 | 16 Mar 2023 | 0.28 Cash |
| 11 Nov 2022 | 03 Nov 2022 | 15 Dec 2022 | 0.28 Cash |
| 10 Nov 2022 | 03 Nov 2022 | 15 Dec 2022 | 0.28 Cash |
| 12 Aug 2022 | 04 Aug 2022 | 15 Sep 2022 | 0.28 Cash |
| 13 May 2022 | 05 May 2022 | 16 Jun 2022 | 0.28 Cash |
| 25 Feb 2022 | 17 Feb 2022 | 17 Mar 2022 | 0.28 Cash |
| 19 Nov 2021 | 11 Nov 2021 | 16 Dec 2021 | 0.28 Cash |
| 20 Aug 2021 | 12 Aug 2021 | 13 Sep 2021 | 0.28 Cash |
| Show more | |||
Annual Dividend Yield
| Year | Annual Dividend ($) | Frequency/Year | Yield % |
|---|---|---|---|
| 2025 | 0.280 | 1 | 3.91 |
| 2024 | 1.12 | 4 | 7.51 |
| 2023 | 1.12 | 4 | 7.77 |
| 2022 | 1.40 | 5 | 5.01 |
| 2021 | 0.560 | 2 | 1.84 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |